This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Explore US market cap tilt retirement funds to adjust exposure. The intro covers when tilting helps and how to implement a balanced approach.
28,282 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
A multi trillion funding surge is intensifying the race to dominate AI, as tech giants and investors flood capital in...
NVIDIA has stunned investors with a dramatic dividend move and a massive buyback. This article breaks down what it me...
Taiwan just enacted sweeping crypto legislation that brings licensing for virtual asset firms and new rules for stabl...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
As homes grow pricier and college costs climb, some parents are choosing to fund down payments for Gen Z rather than ...
Zero Network, a gasless Ethereum Layer 2 project, is closing its standalone chain after about 18 months of operation....
The space economy is expanding, yet investing in it without a plan can blow up portfolios. This guide explains why wa...
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...
PepsiCo unveils a landmark Asia strategy, reframing markets into three asias, three different playbooks to capture gr...
Two-week ETF redemptions from Bitcoin and Ethereum ETFs total roughly $2.66 billion, but the flow points to a rotatio...